More information
Risk premiums on corporate bonds?
The risk premiums on corporate bonds are close to their lows. What are the reasons? Is a correction imminent or is everything perhaps completely different on the bond market this time?
Biotechnology shares at the start of an upswing?
Biotechnology shares have been in the spotlight again since the beginning of the year. Successes in research and market approvals for new drugs could provide fresh impetus. Is the sector worth a look?